Deva Holding was hit with a patent infringement lawsuit on Oct. 30 in Delaware District Court over its plans to market generic versions of the psychiatric drug Vraylar. The action, brought by AbbVie, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results